Scala Biodesign

Drug Discovery · AI for Science

Facts

as of Nov 16, 2026

Headquartered in Tel Aviv, Israel, Scala Biodesign is a biotechnology company developing computational protein design and enzyme engineering software. Through its proprietary cloud platform, ScalaOS, the company integrates atomistic physics-based modeling, evolutionary data, and artificial intelligence to design stable, high-performance proteins, antibodies, and enzymes. By enabling one-shot optimization that significantly boosts production yields, thermostability, and catalytic activity while reducing experimental screening rounds, it empowers biopharmaceutical, chemical, and industrial biotech companies worldwide to accelerate drug discovery and bioprocess development.

Headquarters
Tel Aviv, Israel
Employees
11-50estimated range
Website
scala-bio.com

These are the key facts about Scala Biodesign on Alion as of Nov 16, 2026. Scala Biodesign is headquartered in Tel Aviv, Israel. The latest round is Series A of $16M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
Tel AvivBusiest site
SiteTypeOpen rolesHires most forEngineering
Tel Aviv IsraelHeadquarters5Backend, Industrial Engineering, AI/ML60%
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$16MTotal raised
Series ALatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2026$16M1 record
Largest rounds and grants
$16M
Sources: funding announcements, grant and company registers

Technologies named in job postings at Scala Biodesign over the last 12 months, by layer, with the share of postings for each.

10Technologies in use
5Postings analysed
76/100Stack modernity
Frameworks & librariesPyTorch
Cloud & platformsKubernetesTogether AI
Sign in to see how your skills match this stackSign In
Full Scala Biodesign tech stack10 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

Mar 31
Dec 2021
Each milestone is dated by its source: registers, filings, the press

Newsroom

Apr 22026
News · Pulse 2.0
Scala Biodesign announced it has raised $16 million in a Series A financing round, bringing its total funding to $21.5 million since its founding in 2022. The round was led by Gr…
Mar 312026
News · YahooFinance
TEL AVIV, Israel, March 31, 2026--Scala Biodesign Raises $16M Series A Financing to Accelerate Development of Protein-Based Products with ScalaOS
Nov 2, 20252025
Blog
Scala's technology enables heat-stable, low-cost malaria vaccine protein to allow widespread use Why it matters Vaccines intended for widespread use in regions with unreliable el…
Nov 1, 20252025
Blog
Scala's technology stabilizes a dynamic target to accelerate drug discovery In collaboration with: Why it matters Structural information on protein targets is a cornerstone of dr…
Oct 31, 20252025
Blog
Scala's underlying technology enabled thermostable, long-lived enzyme variants that improve survival and brain function in neuronopathic Gaucher disease Why it matters Lysosomal…
Oct 30, 20252025
Blog
Scala's one-round computational humanization generates diverse, fully human antibodies with preserved activity Why it matters Classical antibody humanization methods often compro…
Sources: the outlets named on each headline, each story once